Medicija has acquired Saulės Šeimos Medicinos Centras
May 2026 — Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Medicija is a leading fertility services provider in Lithuania with a growing offering across multiple specialist consultation areas. It operates three modern clinics in Vilnius, Kaunas and Klaipėda.
Founded 25 years ago by five family doctors, Saulės Šeimos Medicinos Centras is the largest primary healthcare provider in the Kaunas region, operating four state-of-the-art clinics in the city. The company serves approximately 28,000 registered patients and employs 170 people.
Our role in the transaction
Oaklins’ team in Lithuania acted as the financial advisor to Medicija in the acquisition. This transaction marks the team’s third engagement with Medicija, strengthening the company’s position in the Lithuanian healthcare services market and laying a solid foundation for future growth.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Conozca másLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Conozca másSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
Conozca más